XS
BNTX icon

XR Securities’s BioNTech BNTX Stock Holding History

XR Securities’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,700
Closed -$255K – 428
2022
Q4 		$255K Buy
+1,700
New +$262K 0.02% 403
2021
Q4 		– Sell
-6,400
Closed -$242K – 455
2021
Q3 		$242K Buy
+6,400
New +$2.03M 0.11% 172
2021
Q1 		– Sell
-9,200
Closed -$286K – 480
2020
Q4 		$286K Buy
+9,200
New +$903K 0.02% 144

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

XR Securities's BNTX Position: Q4 2021 in Review

XR Securities sold out of BioNTech (BNTX) in Q4 2021, closing a stake of 1,879 shares — an estimated $515K sold.

XR Securities first reported a position in BNTX in Q4 2020 and held it in 2 quarters. The position peaked at $667K in Q4 2020. 354 funds tracked by Wall St. Rank hold BNTX as of Q4 2021.

  • XR Securities reported no remaining BioNTech position as of Q4 2021 after selling out during the quarter.
  • XR Securities sold 1,879 BioNTech shares in Q4 2021, an estimated $515K.
  • XR Securities first reported a position in BioNTech in Q4 2020 and held it in 2 quarters.
  • XR Securities's BioNTech position peaked at $667K in Q4 2020.
  • 354 funds tracked by Wall St. Rank held BioNTech as of Q4 2021.

Based on XR Securities's 13F filing for Q4 2021, filed 10 Jan 2022.